Proactive Therapeutic Concentration Monitoring of Infliximab May Improve Outcomes for Patients with Inflammatory Bowel Disease: Results from a Pilot Observational Study

BACKGROUND: Infliximab (IFX) is effective in the treatment of inflammatory bowel disease; however, the effect is often not durable. It is unknown if proactive therapeutic concentration monitoring (TCM) of IFX improves outcomes. METHODS: This is a retrospective observational study examining the use o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Inflamm Bowel Dis
Main Authors: Vaughn, Byron P., Martinez-Vazquez, Manuel, Patwardhan, Vilas R., Moss, Alan C., Sandborn, William J., Cheifetz, Adam S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5557346/
https://ncbi.nlm.nih.gov/pubmed/25192499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MIB.0000000000000156
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados